Statin On-Board May Cut Cancer Risk in HIV Infection (CME/CE)

Individuals infected with human immunodeficiency virus (HIV) who are on statin therapy are significantly less likely to develop cancer, researchers said here at the International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention.

In a retrospective analysis, Vincenzo Spagnuolo, MD, a resident in infectious diseases at Ospedale San Raffaele, Milan, observed that 363 individuals out of 4617 who were not on statins (7.9%) were diagnosed with cancer compared with 12 of 740 patients on statins (1.3%).